Top Markets
#1 DogBull DogBull +106.08%
#2 ADO Protocol ADO Protocol +50.83%
#3 Siacoin Siacoin +43.08%
#4 The Bitcoin Bull The Bitcoin Bull +38.16%
#5 MarsCoin MarsCoin +36.76%
#6 Ontology Gas Ontology Gas +25.44%
#7 UnifAI Network UnifAI Network +23.80%
#8 Glidr Glidr +23.51%
#9 Useless Coin Useless Coin +20.49%
#10 Falcon Finance Falcon Finance +17.59%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Medios AG Medios AG

Medios AG

ILM1
Rank in Stocks #15688
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Share Price
$13.21
Market Cap
$337.03M
Change (1 day)
-0.36%
Change (1 year)
-28.32%
Country
DE
Trade Medios AG (ILM1)

Category

Healthcare
Revenue for Medios AG (ILM1)
Revenue in Sep 2026 TTM: 0
According to Medios AG latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Medios AG from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 $410.98B -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 $254.25B -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 $7.64B -
AU